Rituximab Use in the Management of Childhood Nephrotic Syndrome
Childhood nephrotic syndrome is a challenging and often persistent renal disorder, and its incidence varies between different ethnicities and regions. Corticosteroids have been the main treatment for decades and are effective in most children with idiopathic NS, although 10–15% of these children bec...
Main Authors: | Mahmoud Kallash, William E. Smoyer, John D. Mahan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2019.00178/full |
Similar Items
-
Management of idiopathic nephrotic syndrome in childhood
by: Peco-Antić Amira
Published: (2004-01-01) -
Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
by: China Nagano, et al.
Published: (2019-08-01) -
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
by: Ryosuke Usui, et al.
Published: (2018-10-01) -
Clinical case of steroid-dependent nephrotic syndrome in a child
by: Ye. Lagodych, et al.
Published: (2023-06-01) -
Rituximab use in the treatment of children with nephrotic syndrome
by: L.I. Vakulenko, et al.
Published: (2022-06-01)